4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Inventiva S.A. (IVA) operates in the Biotechnology industry and is headquartered in Daix, France with about 69 employees. Its market capitalization is roughly €917 million. In the fiscal year ended 2025-12-31, IVA reported €4M in revenue and (€354M) in net income.
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €4M | €9M | €18M | €12M | — |
| Operating Income (EBIT) | (€133M) | (€94M) | (€103M) | (€57M) | — |
| Net Income | (€354M) | (€184M) | (€110M) | (€54M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | €0M | €0M | €0M | — | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €250M | €119M | €70M | €116M | — |
| Total Liabilities | €278M | €226M | €102M | €70M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IVA viewer.
About TickerBase · Data methodology & sources · Privacy · Terms